NCT06429514Completed
Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression
Based on the Theory of Gut-brain Axis, the Intervention Effect and Related Mechanism of Ganoderma Lucidum Spore Powder on Depressive Symptoms in Patients With Thyroid Cancer Were Investigated
Source: ClinicalTrials.gov · Last updated 28 May 2024
Brief summary (registry, in English)
To clarify the clinical effect of Ganoderma lucidum spore powder intervention on postoperative depressive symptoms of papillary thyroid carcinoma ; to elucidate the antidepressant mechanism of Ganoderma lucidum spore powder.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 298 (actual)
- First submitted
- 15 May 2024
- Start date
- 28 Mar 2023
- Primary completion date
- 3 May 2024
- Lead sponsor
- Ling Zhiqiang
- Diseases
- Thyroid cancer
- NCT number
- NCT06429514
What you commit to
- Study type: Interventional
- Participants enrolled: 298
- From 28 Mar 2023 to the primary completion date, 3 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Gastrointestinal surgery was performed before intervention
- Including patients with other malignant tumors, who need chemotherapy, radiotherapy, biological therapy or traditional Chinese medicine treatment received antibiotics or microecological modulators within 3 months before the intervention
Other illness
- suffering from other diseases of the intestinal system
- Patients with severe depressive symptoms who must receive antidepressant treatment organic diseases such as heart and brain diseases, brain trauma history of mental illness, use of psychoactive drugs such as drugs
Other
- Acute intestinal obstruction
- Severe liver and kidney dysfunction
- Pregnancy, lactation
Who the study is looking for
- patients with depressive symptoms after surgery for papillary thyroid carcinoma in the outpatient department of Zhejiang Cancer Hospital
- Han nationality
- No previous depression and other mental diseases
- 18-80 years old
- Women
- BMI 19 \~ 24
Age in the registry: 18 years to 80 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zhejiang Cancer Hospital Coordinator of this site? Confirm its status | Hangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.